The good profitability is mainly consequence of the continued good sales performance and successful cost management in the Orion Pharma business division. Also the full-year net sales and operating profit of the Orion Group are anticipated to improve from the previous year.
The Interim Report 1-3/2005 of the Orion Group will be published on Wednesday, 11 May 2005.
Jukka Viinanen Olli Huotari
CEO General Counsel
Jukka Viinanen, President and CEO, Orion Corporation, phone +358 10 429 3710
Jari Karlson, CFO, Orion Group, phone +358 50 429 2883
Orionintie 1A, 02200 Espoo